| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,210 |
6,336 |
$1.24M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,909 |
6,315 |
$992K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,879 |
3,911 |
$751K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,165 |
1,142 |
$727K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,011 |
1,693 |
$182K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
889 |
756 |
$170K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,227 |
470 |
$81K |
| 87581 |
|
1,259 |
1,234 |
$63K |
| G0378 |
Hospital observation service, per hour |
203 |
146 |
$56K |
| 80053 |
Comprehensive metabolic panel |
6,974 |
5,992 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,331 |
6,901 |
$50K |
| 71046 |
Radiologic examination, chest; 2 views |
1,070 |
1,021 |
$35K |
| 94761 |
|
9,181 |
8,412 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
753 |
659 |
$30K |
| 80050 |
General health panel |
448 |
441 |
$27K |
| 84702 |
|
1,007 |
844 |
$25K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,519 |
1,234 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,736 |
1,315 |
$21K |
| 59025 |
Fetal non-stress test |
120 |
41 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
1,005 |
925 |
$15K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
361 |
354 |
$15K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
805 |
733 |
$14K |
| 87400 |
|
646 |
636 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,528 |
1,508 |
$13K |
| 70450 |
Computed tomography, head or brain; without contrast material |
168 |
163 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
677 |
659 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
426 |
419 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
808 |
758 |
$10K |
| 87806 |
|
184 |
182 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
173 |
106 |
$9K |
| 81001 |
|
4,659 |
4,223 |
$9K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,060 |
939 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
289 |
287 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
39 |
38 |
$7K |
| 80061 |
Lipid panel |
955 |
948 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,406 |
1,304 |
$7K |
| 86592 |
|
901 |
865 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,105 |
997 |
$6K |
| 83690 |
|
1,185 |
1,094 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
13,065 |
10,614 |
$6K |
| 84484 |
|
1,549 |
1,173 |
$5K |
| 87070 |
|
395 |
386 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
746 |
722 |
$5K |
| 76818 |
|
40 |
12 |
$5K |
| 83605 |
|
549 |
488 |
$4K |
| 87088 |
|
793 |
733 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
13 |
$3K |
| 85610 |
|
1,242 |
1,140 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68 |
46 |
$3K |
| 85730 |
|
275 |
265 |
$3K |
| 82550 |
|
1,230 |
957 |
$2K |
| 84439 |
|
133 |
133 |
$2K |
| 84703 |
|
270 |
263 |
$2K |
| 82950 |
|
218 |
216 |
$2K |
| 83880 |
|
235 |
201 |
$2K |
| 87040 |
|
166 |
119 |
$2K |
| 83735 |
|
590 |
512 |
$2K |
| 83874 |
|
1,076 |
844 |
$1K |
| 87280 |
|
67 |
67 |
$1K |
| 82553 |
|
1,127 |
873 |
$1K |
| 94760 |
|
893 |
857 |
$1K |
| 84442 |
|
175 |
165 |
$766.91 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
25 |
25 |
$621.09 |
| 81025 |
|
60 |
60 |
$580.40 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
67 |
60 |
$504.29 |
| 82951 |
|
24 |
24 |
$496.30 |
| 82150 |
|
80 |
74 |
$468.56 |
| 93041 |
|
149 |
140 |
$259.20 |
| 86803 |
|
12 |
12 |
$227.04 |
| 82009 |
|
28 |
26 |
$207.66 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
693 |
597 |
$196.90 |
| 87186 |
|
67 |
64 |
$195.07 |
| 87077 |
|
67 |
64 |
$182.22 |
| 82977 |
|
12 |
12 |
$114.51 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
74 |
31 |
$56.21 |
| 85652 |
|
14 |
13 |
$41.99 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$23.44 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$0.00 |
| 96367 |
|
13 |
12 |
$0.00 |